3
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase II:
1
Phase I (Other):
2
Phase II
1 trial-
EndedBayer Consumer Care AG CommercialELINZANETANT
Phase I (Other)
2 trials-
EndedBayer Consumer Care AG CommercialIMP not specified
-
EndedBayer Consumer Care AG CommercialELINZANETANT
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Bayer Consumer Care AG | Commercial | 3 | Phase I (Other), Phase II | 0 |
New trials by year
2023
2
2024
1